Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022

SELL
$76.72 - $92.68 $8.55 Million - $10.3 Million
-111,457 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$76.02 - $88.62 $131,894 - $153,755
-1,735 Reduced 1.53%
111,457 $8.83 Million
Q4 2020

Jan 29, 2021

SELL
$46.01 - $68.74 $200,327 - $299,293
-4,354 Reduced 3.7%
113,192 $7.49 Million
Q3 2020

Nov 10, 2020

SELL
$41.91 - $57.81 $150,959 - $208,231
-3,602 Reduced 2.97%
117,546 $5.31 Million
Q2 2020

Aug 07, 2020

SELL
$39.87 - $56.9 $71,805 - $102,476
-1,801 Reduced 1.46%
121,148 $5.83 Million
Q1 2020

Apr 28, 2020

SELL
$34.22 - $76.49 $1.88 Million - $4.21 Million
-55,000 Reduced 30.91%
122,949 $5.56 Million
Q4 2019

Feb 12, 2020

SELL
$68.92 - $85.27 $4.86 Million - $6.02 Million
-70,565 Reduced 28.39%
177,949 $13.4 Million
Q3 2019

Oct 29, 2019

BUY
$71.74 - $86.35 $205,750 - $247,651
2,868 Added 1.17%
248,514 $18.3 Million
Q1 2019

Apr 22, 2019

SELL
$86.15 - $100.49 $268,357 - $313,026
-3,115 Reduced 1.25%
245,646 $23.9 Million
Q4 2018

Jan 25, 2019

BUY
$84.14 - $125.42 $284,645 - $424,295
3,383 Added 1.38%
248,761 $22.8 Million
Q3 2018

Oct 24, 2018

BUY
$101.02 - $130.95 $8.32 Million - $10.8 Million
82,378 Added 50.54%
245,378 $30.4 Million
Q1 2018

May 11, 2018

SELL
$79.95 - $89.74 $1.92 Million - $2.16 Million
-24,022 Reduced 12.84%
163,000 $14.4 Million
Q1 2018

Apr 19, 2018

SELL
$79.95 - $89.74 $797,741 - $895,425
-9,978 Reduced 5.06%
187,022 $16.6 Million
Q3 2017

Oct 17, 2017

BUY
$60.32 - $70.06 $11.9 Million - $13.8 Million
197,000
197,000 $13.8 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.